A 19-year-old male complains of Shoness of breath associated with wheezing after he takes aspirin for headache. In cases of aspirin hypersensitivity, which of the following mediators will be responsible for above mentioned condition?
First, I need to recall what aspirin hypersensitivity involves. I remember that aspirin can cause bronchoconstriction in some people, especially those with asthma. This is related to the inhibition of cyclooxygenase (COX) enzymes. Aspirin inhibits COX-1 and COX-2, which are involved in the production of prostaglandins and thromboxanes. But when COX is inhibited, there's a shunting of arachidonic acid metabolism towards the lipoxygenase pathway, leading to increased leukotriene production. Leukotrienes are potent bronchoconstrictors and can cause inflammation in the airways. So, maybe leukotrienes are the key here.
The options are not given, but common mediators in allergic or hypersensitivity reactions include histamine, leukotrienes, prostaglandins, and others like bradykinin. Since the reaction is due to aspirin, which affects COX pathways, the mediator would likely be from the lipoxygenase pathway. So leukotrienes, specifically LTE4 or LTC4, are involved in this type of reaction.
Histamine is more associated with IgE-mediated reactions, like anaphylaxis, but aspirin hypersensitivity is not IgE-mediated. It's a non-IgE mechanism related to enzyme inhibition. Prostaglandins are inhibited here, leading to their decrease, but the problem is more about the overproduction of leukotrienes. So the correct answer should be leukotrienes.
For the wrong options, if any of the options were histamine, that would be incorrect because it's not IgE-mediated. If prostaglandins were an option, their role is more about being blocked, not causing the symptoms. Bradykinin might be involved in some reactions, but not specifically here. So, the mediator responsible is leukotrienes, particularly LTC4 or LTE4.
**Core Concept**
Aspirin hypersensitivity in susceptible individuals (e.g., asthmatics) involves shunting of arachidonic acid metabolism from cyclooxygenase (COX) to lipoxygenase pathways. This leads to overproduction of cysteinyl leukotrienes (e.g., LTC4, LTD4, LTE4), which mediate bronchoconstriction, inflammation, and airway edema.
**Why the Correct Answer is Right**
Aspirin irreversibly inhibits COX-1 and COX-2, reducing prostaglandin synthesis. In aspirin-sensitive patients, this triggers increased 5-lipoxygenase activity, converting arachidonic acid into leukotrienes. Cysteinyl leukotrienes are potent bronchoconstrictors and increase vascular permeability, causing wheezing and respiratory distress. This mechanism is distinct from IgE-mediated allergic reactions and is termed "aspirin-exacerbated respiratory disease" (AERD).
**Why Each Wrong Option is Incorrect**
**Option A:** Histamine is released in IgE-mediated anaphylaxis but not in AERD.
**Option B:**